FDA.reportPublic FDA data

24 HR Pristiq 25 MG Extended Release Oral Tablet

RxCUI
1607619
RxNorm name
24 HR Pristiq 25 MG Extended Release Oral Tablet
Display name
24 HR Pristiq 25 MG Extended Release Oral Tablet
Full name
24 HR Pristiq 25 MG Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Pristiq Extended-ReleaseDESVENLAFAXINE SUCCINATEWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.0f43610c-f290-46ea-d186-4f998ed99fce2026-04-28Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1607619

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0f43610c-f290-46ea-d186-4f998ed99fcePristiq 25 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR desvenlafaxine succinate 25 MG Extended Release Oral Tablet [Pristiq] [SBD] · 24 HR Pristiq 25 MG Extended Release Oral Tablet [SY] · Pristiq 25 MG (as desvenlafaxine succinate 38 MG) 24 HR Extended Release Oral Tablet [SY]467These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 200820260428